Par Drugs and Chemicals Limited

Informe acción NSEI:PAR

Capitalización de mercado: ₹3.1b

Salud financiera de hoja de balance de Par Drugs and Chemicals

Salud financiera controles de criterios 6/6

Par Drugs and Chemicals tiene un patrimonio de accionistas total de ₹786.0M y una deuda total de ₹0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son ₹956.6M y ₹170.6M respectivamente. El BAIT de Par Drugs and Chemicals es de ₹187.1M, por lo que su ratio de cobertura de intereses es de -164.4. Tiene efectivo e inversiones a corto plazo que ascienden a ₹298.5M.

Información clave

0%

Ratio deuda-patrimonio

₹0

Deuda

Ratio de cobertura de intereses183.2x
Efectivo₹366.54m
Patrimonio₹856.32m
Total pasivo₹159.79m
Activos totales₹1.02b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Apr 16
Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Apr 05
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

Nov 03
Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

May 19
If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Mar 17
Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Oct 22
Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Aug 11
Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Jul 14
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Mar 31
Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Mar 05
Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Feb 06
Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Jan 10
Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Dec 13
How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹540.5M) de PAR superan a sus pasivos a corto plazo (₹133.0M).

Pasivo a largo plazo: Los activos a corto plazo de PAR (₹540.5M) superan a sus pasivos a largo plazo (₹37.6M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: PAR está libre de deudas.

Reducción de la deuda: PAR no tiene deuda en comparación con hace 5 años, cuando su ratio deuda-patrimonio era de 53.4%.

Cobertura de la deuda: PAR no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: PAR no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.

Hoja de balance

Descubre empresas con salud financiera

7D

1Y

7D

1Y

7D

1Y